Silymarin extract outperforms its nanomodified form in inhibiting colon cancer cell proliferation
This study demonstrates that native Silymarin extract exhibits superior anticancer efficacy and selectivity against colon cancer cells compared to its nanomodified form by inhibiting MAPK proliferation pathways and activating P53-mediated apoptosis while sparing normal epithelial cells.